Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Hemab secures $135m in Series B funding for rare bleeding disorder treatment

February 21, 2023 Research and Development

Hemab Therapeutics announced it received $135m from their oversubscribed Series B funding round. The funding will be used for their …
News

Scancell shares encouraging results from phase 1/2 cancer trial

February 21, 2023 Research and Development

Scancell Holdings PLC have shared early results from its phase 1/2 cancer study which appear “very encouraging”, according to one …
News

Scancell shares “highly encouraging” results from phase 1 COVID-19 vaccine trial

February 13, 2023 Research and Development

Scancell Holdings PLC has shared “highly encouraging” results from its phase 1 clinical trial of its COVID-19 vaccines, says chief …
News

SynaptixBio secures FDA Rare Paediatric Disease designation to develop treatments for TUBB4a leukodystrophy

February 10, 2023 Research and Development

SynaptixBio, a UK-based biotech firm, has been granted FDA Rare Paediatric Disease (RPD) designation – an accolade which encourages the …
News

FDA approves Regeneron’s Eylea for the treatment of retinopathy of prematurity in infants

February 9, 2023 Research and Development

The FDA has approved Regeneron Pharmaceuticals’ Eylea (aflibercept) injection for the treatment of retinopathy of prematurity (ROP) in preterm infants. …
News

Johnson & Johnson’s Ethicon undertakes first robot-assisted kidney stone removal

February 8, 2023 Research and Development

Johnson & Johnson (J&J) medtech company, Ethicon, has announced its first robotic-assisted kidney stone removal using its Monarch platform. The …
News

Sandoz files Amgen biosimilar drug for osteoporosis

February 8, 2023 Research and Development

Switzerland-based Sandoz has filed a proposed biosimilar of Amgen’s osteoporosis drug Prolia/Xgeva with the FDA. According to Sandoz, over 10 …
News

4D Molecular Therapeutics’ Fabry Gene Therapy put on FDA-mandated hold

February 7, 2023 Research and Development

4D Molecular Therapeutics has had its gene therapy programme 4D-310 put on clinical hold by the FDA after adverse side …
News

SPR Therapeutics gains FDA extended approval for pain management system

February 6, 2023 Research and Development

Pain management medical device company SPR Therapeutics has obtained expanded approval from the FDA for its SPRINT Peripheral Nerve System …
News

Australia’s TGA approves psychedelics to treat mental health conditions

February 6, 2023 Research and Development

Australia’s Therapeutic Goods Administration (TGA) has announced its approval of the use of psychedelics to treat certain mental health conditions. …
News

Insilico Medicine opens new R&D facility in Abu Dhabi

February 3, 2023 Research and Development

Hong Kong-based healthtech company Insilico Medicine recently opened its eighth global laboratory in Abu Dhabi.   Utilising Abu Dhabi’s Masdar …
News

Adding veliparib to chemotherapy can extend progression-free survival in in some breast cancer patients

February 1, 2023 Research and Development

It appears that adding veliparib to chemotherapy can extend progression-free survival (PFS) in patients suffering from triple negative breast cancer …
News

NaDeNo’s nanomedicine delivery system inspires hope for peritoneal cancer

February 1, 2023 Research and Development

NaDeNo, a new nanomedicines company and spin-off of the Norwegian science institute SINTEF, has revealed promising results for its cure …
News

Aptar Pharma releases recyclable nasal spray pump

January 31, 2023 Research and Development

US-based drug delivery systems company Aptar Pharma has released its first metal-free, multidose nasal spray. APF Futurity delivers multidose nasal …
News

First Wave BioPharma announces phase 2 trial

January 31, 2023 Research and Development

Clinical-stage biopharmaceutical company, First Wave BioPharma, has announced that it is planning to begin its phase 2 clinical trial of …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025